Paromomysin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL), according to a randomized, double blind study conducted in Panama. Leishmaniasis, transmitted by a female phlebotomine sand fly bite, is endemic in 98 countries and has approximately 0.7 to 1.2 million CL cases each year.
Click here for original story, Topical cream found as less-toxic therapy to treat cutaneous leishmaniasis
Source: ScienceDaily